A. Klimke

2.6k total citations
79 papers, 1.7k citations indexed

About

A. Klimke is a scholar working on Psychiatry and Mental health, Pharmacology and Cognitive Neuroscience. According to data from OpenAlex, A. Klimke has authored 79 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Psychiatry and Mental health, 17 papers in Pharmacology and 14 papers in Cognitive Neuroscience. Recurrent topics in A. Klimke's work include Schizophrenia research and treatment (28 papers), Treatment of Major Depression (12 papers) and Psychiatric care and mental health services (8 papers). A. Klimke is often cited by papers focused on Schizophrenia research and treatment (28 papers), Treatment of Major Depression (12 papers) and Psychiatric care and mental health services (8 papers). A. Klimke collaborates with scholars based in Germany, United States and Spain. A. Klimke's co-authors include U. Henning, Ursula Voss, Wolfgang Gäebel, Rolf Larisch, Judith Koppehele‐Gossel, R. Holzmann, Allan Hobson, Michael A. Nitsche, H. Vosberg and Walter Paulus and has published in prestigious journals such as Nature Neuroscience, PLoS ONE and NeuroImage.

In The Last Decade

A. Klimke

78 papers receiving 1.6k citations

Peers

Countries citing papers authored by A. Klimke

Since Specialization

Citations

This map shows the geographic impact of A. Klimke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Klimke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Klimke more than expected).

Fields of papers citing papers by A. Klimke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Klimke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Klimke. The network helps show where A. Klimke may publish in the future.

Co-authorship network of co-authors of A. Klimke

This figure shows the co-authorship network connecting the top 25 collaborators of A. Klimke. A scholar is included among the top collaborators of A. Klimke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Klimke. A. Klimke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Off-label use of antidepressants, antipsychotics, and mood-stabilizers in psychiatry 2022 ·Journal of Neural Transmission ·Gudrun Hefner, Jan Wolff, Sermin Toto, (unknown), A. Klimke	8
2	Predicting the risk of drug–drug interactions in psychiatric hospitals: a retrospective longitudinal pharmacovigilance study 2021 ·BMJ Open ·Jan Wolff, Gudrun Hefner, Claus Normann, Klaus Kaier, Harald Binder, Katharina Domschke, Christoph Hiemke, Michael Marschollek, A. Klimke	9
3	Current use of anticholinergic medications in a large naturalistic sample of psychiatric patients 2021 ·Journal of Neural Transmission ·Sermin Toto, Gudrun Hefner, Martina Hahn, Christoph Hiemke, (unknown), Jan Wolff, A. Klimke	9
4	Pharmacotherapy, drug-drug interactions and potentially inappropriate medication in depressive disorders 2021 ·PLoS ONE ·Jan Wolff, (unknown), Gudrun Hefner, Claus Normann, Klaus Kaier, Harald Binder, Christoph Hiemke, Sermin Toto, Katharina Domschke, Michael Marschollek, A. Klimke	18
5	Dreaming during REM sleep: autobiographically meaningful or a simple reflection of a Hebb'ian-based memory consolidation process? 2019 ·ARCHIVES ITALIENNES DE BIOLOGIE ·Voss Voss, A. Klimke	11
6	Vergütungssystem für Psychiatrie und Psychosomatik 2014 ·Der Nervenarzt ·A. Klimke, (unknown), Ricardo Berton, Margitta Borrmann-Hassenbach, (unknown), Roland Nitschke, (unknown), Martin Schillinger, F. Godemann	7
7	Abbildung des psychiatrisch-psychotherapeutischen Leistungsspektrums durch die aktuellen OPS-Komplexcodes 2011 ·Psychiatrische Praxis ·(unknown), (unknown), (unknown), Dyrk Zedlick, (unknown), A. Klimke	1
8	Clomipramine-induced serum prolactin as a marker for serotonin and dopamine turnover: results of an open label study 2011 ·European Archives of Psychiatry and Clinical Neuroscience ·Joachim Cordes, Kai G. Kahl, Christian Werner, U. Henning, (unknown), Rolf Larisch, Christian Schmidt-Kraepelin, (unknown), M.W. Agelink, (unknown), Thomas Hohlfeld, Wolfgang Gäebel, A. Klimke	4
9	Clozapine Mobilizes CD34+ Hematopoietic Stem and Progenitor Cells and Increases Plasma Concentration of Interleukin 6 in Patients With Schizophrenia 2010 ·Journal of Clinical Psychopharmacology ·(unknown), A. Klimke, Ralf Kronenwett, Guido Kobbe, Rainer Haas, Karin Fehsel	28
10	Clozapine therapy raises serum concentrations of high sensitive C-reactive protein in schizophrenic patients 2010 ·International Clinical Psychopharmacology ·(unknown), (unknown), Karin Fehsel, A. Klimke	35
11	Möglichkeiten des Gewichtsmanagements in der Behandlung schizophrener Psychosen mit atypischen Antipsychotika 2008 ·Fortschritte der Neurologie · Psychiatrie ·(unknown), (unknown), K.G. Kahl, (unknown), (unknown), Christian Lange‐Asschenfeldt, Hans Hauner, M.W. Agelink, A. Klimke	2
12	Increased serum S100B in elderly, chronic schizophrenic patients: Negative correlation with deficit symptoms 2005 ·Schizophrenia Research ·Andrea Schmitt, Thomas Bertsch, U. Henning, Heike Tost, A. Klimke, Fritz A. Henn, Peter Falkai	63
13	Neuropsychological measures of attention and memory function in schizophrenia: relationships with symptom dimensions and serum monoamine activity 2005 ·Behavioral and Brain Functions ·Robert D. Oades, Bernd Röpcke, U. Henning, A. Klimke	8
14	Influence of atypical neuroleptics on executive functioning in patients with schizophrenia: a randomized, double-blind comparison of olanzapine vs. clozapine 2005 ·The International Journal of Neuropsychopharmacology ·Stefan Bender, Alexandra Dittmann-Balçar, Ulrich Schall, Jörg Wolstein, A. Klimke, Michael Riedel, (unknown), Kai‐Uwe Kühn, Martin Lambert, Regina Dittmann, Dieter Naber	47
15	Antipsychotic drugs influence transport of the β-adrenergic antagonist [³H]-dihydroalprenolol into neuronal and blood cells 2004 ·The World Journal of Biological Psychiatry ·(unknown), A. Klimke, U. Henning	5
16	Reversible Neutropenia during Treatment with Olanzapine: Three Case Reports 2004 ·The World Journal of Biological Psychiatry ·Joachim Cordes, Marcus R. Streit, (unknown), Martina von Wilmsdorff, M.W. Agelink, A. Klimke	13
17	Influence of synaptic serotonin level on [18F]altanserin binding to 5HT2 receptors in man 2003 ·Behavioural Brain Research ·Rolf Larisch, A. Klimke, Kurt Hamacher, U. Henning, (unknown), Thomas Hohlfeld, H. Vosberg, Marco Tosch, Wolfgang Gäebel, Heinz H. Coenen, (unknown)	23
18	Relations of clinical features, subgroups and medication to serum monoamines in schizophrenia 2002 ·Human Psychopharmacology Clinical and Experimental ·Robert D. Oades, A. Klimke, U. Henning, Marie Luise Rao	11
19	Veränderungen der Serotonin-5HT2-Rezeptoren bei remittierten Patienten mit hereditärer Depression = Disturbance of serotonin 5HT2 receptors in remitted patients suffering from hereditary depressive disorder 2001 ·JuSER (Forschungszentrum Jülich) ·Rolf Larisch, Fermín Mayoral, Marco Tosch, H.-W. Müller-Gärtner, A. Klimke, K. Hamacher, (unknown), Heinz H. Coenen, Fernando Silva, H. Vosberg, Herbert Herzog	10
20	The Efficacy of Cavain in Patients Suffering from Anxiety 1989 ·Pharmacopsychiatry ·E. Lehmann, E. Klieser, A. Klimke, (unknown), R Spatz	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact